These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 22970329)
1. Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness. Kuepfer I; Schmid C; Allan M; Edielu A; Haary EP; Kakembo A; Kibona S; Blum J; Burri C PLoS Negl Trop Dis; 2012 Aug; 6(8):e1695. PubMed ID: 22970329 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial. Burri C; Nkunku S; Merolle A; Smith T; Blum J; Brun R Lancet; 2000 Apr; 355(9213):1419-25. PubMed ID: 10791526 [TBL] [Abstract][Full Text] [Related]
3. An alternative form of melarsoprol in sleeping sickness. Kennedy PG Trends Parasitol; 2012 Aug; 28(8):307-10. PubMed ID: 22704910 [TBL] [Abstract][Full Text] [Related]
4. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis. Nok AJ Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807 [TBL] [Abstract][Full Text] [Related]
5. Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania. Kibona SN; Matemba L; Kaboya JS; Lubega GW Trop Med Int Health; 2006 Feb; 11(2):144-55. PubMed ID: 16451338 [TBL] [Abstract][Full Text] [Related]
6. Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis. Blum J; Nkunku S; Burri C Trop Med Int Health; 2001 May; 6(5):390-400. PubMed ID: 11348533 [TBL] [Abstract][Full Text] [Related]
7. Attempt to correlate urine arsenic excretion with clinical course during melarsoprol therapy of patients with Rhodesian trypanosomiasis. Harrison SM; Harris RW; Bales JD Am J Trop Med Hyg; 1997 Jun; 56(6):632-6. PubMed ID: 9230794 [TBL] [Abstract][Full Text] [Related]
8. Lesson of the month: a psychiatric diagnosis overturned by a blood film. Wise E; Easom N; Watson J; Bailey R; Brown M Clin Med (Lond); 2012 Jun; 12(3):295-6. PubMed ID: 22783788 [No Abstract] [Full Text] [Related]
9. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness. Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469 [TBL] [Abstract][Full Text] [Related]
10. Metronidazole and suramin combination in the treatment of arsenical refractory Rhodesian sleeping sickness--a case study. Foulkes JR Trans R Soc Trop Med Hyg; 1996; 90(4):422. PubMed ID: 8882195 [No Abstract] [Full Text] [Related]
11. Clinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and Uganda. Kuepfer I; Hhary EP; Allan M; Edielu A; Burri C; Blum JA PLoS Negl Trop Dis; 2011 Mar; 5(3):e968. PubMed ID: 21407802 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness. Schmid C; Nkunku S; Merolle A; Vounatsou P; Burri C Lancet; 2004 Aug 28-Sep 3; 364(9436):789-90. PubMed ID: 15337407 [TBL] [Abstract][Full Text] [Related]
13. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985]. Pérez Martín O; Lastre González M; Urban M; Shwalbach J Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188 [TBL] [Abstract][Full Text] [Related]
14. The treatment of human African trypanosomiasis. Pépin J; Milord F Adv Parasitol; 1994; 33():1-47. PubMed ID: 8122565 [No Abstract] [Full Text] [Related]
15. Randomized controlled trial of three regimens of melarsoprol in the treatment of Trypanosoma brucei gambiense trypanosomiasis. Pépin J; Mpia B Trans R Soc Trop Med Hyg; 2006 May; 100(5):437-41. PubMed ID: 16483622 [TBL] [Abstract][Full Text] [Related]
16. Occurrence of multiple drug resistance in Trypanosoma brucei rhodesiense isolated from sleeping sickness patients. Kagira JM; Maina N Onderstepoort J Vet Res; 2007 Mar; 74(1):17-22. PubMed ID: 17708149 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis. Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303 [TBL] [Abstract][Full Text] [Related]
18. The phenomenon of treatment failures in Human African Trypanosomiasis. Brun R; Schumacher R; Schmid C; Kunz C; Burri C Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845 [TBL] [Abstract][Full Text] [Related]
19. [2 epidemics of arsenical encephalopathy in the treatment of trypanosomiasis, Uganda, 1992-1993]. Ancelle T; Barret B; Flachet L; Moren A Bull Soc Pathol Exot; 1994; 87(5):341-6. PubMed ID: 7496198 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes. Balasegaram M; Young H; Chappuis F; Priotto G; Raguenaud ME; Checchi F Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):280-90. PubMed ID: 18947846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]